These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17086229)

  • 1. [New drug financing model causes concerns].
    Moum B
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2830. PubMed ID: 17086229
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab: getting the most for your money.
    Irving PM; Gibson PR
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1559-61. PubMed ID: 17845681
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in biologic therapy for inflammatory bowel disease].
    Sostegni R; Pera A; Daperno M; Rocca R
    Recenti Prog Med; 2008 Jan; 99(1):10-8. PubMed ID: 18389866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosimilar medicines in inflammatory bowel disease.
    Moum B; Lundin KE
    Tidsskr Nor Laegeforen; 2014 Apr; 134(8):819-20. PubMed ID: 24780979
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
    Roblin X; Phelip JM
    Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases.
    Bujanover Y; Weiss B
    Isr Med Assoc J; 2008; 10(8-9):634-9. PubMed ID: 18847168
    [No Abstract]   [Full Text] [Related]  

  • 7. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
    Lichtenstein GR; Sbreu MT; Cohen R; Tremaine W
    Rev Gastroenterol Mex; 2006; 71(3):351-401. PubMed ID: 17140062
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunobiology of chronic inflammatory bowel diseases].
    Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2657-60. PubMed ID: 17109275
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of infliximab in inflammatory bowel disease needs to be debated.
    de Vries HS; Van Oijen MG; de Jong DJ
    Clin Gastroenterol Hepatol; 2009 May; 7(5):603-4. PubMed ID: 19166980
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?
    Biancone L; Petruzziello C; Calabrese E; Zorzi F; Naccarato P; Onali S; Pallone F
    Gut; 2009 Dec; 58(12):1703. PubMed ID: 19923350
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.
    Stefanelli T; Malesci A; De La Rue SA; Danese S
    Autoimmun Rev; 2008 May; 7(5):364-9. PubMed ID: 18486923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
    Danese S
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of infliximab and other biologic agents in the inflammatory bowel diseases.
    Reddy JG; Loftus EV
    Gastroenterol Clin North Am; 2006 Dec; 35(4):837-55. PubMed ID: 17129816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies target inflammatory bowel disease.
    Hampton T
    JAMA; 2004 Jul; 292(1):29-30. PubMed ID: 15238575
    [No Abstract]   [Full Text] [Related]  

  • 16. Questions regarding use of infliximab and risk of certain viral infections.
    El-Matary W
    Am J Gastroenterol; 2009 Nov; 104(11):2852; author reply 2852-3. PubMed ID: 19888241
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab.
    Barrie A; Plevy S
    Gastroenterol Clin North Am; 2006 Dec; 35(4):883-93. PubMed ID: 17129819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow up of the use of biological drugs against inflammatory bowel diseases].
    Moum B
    Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2841-2. PubMed ID: 17987080
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
    Davenport RJ; Munday JR
    Drug Discov Today; 2007 Jul; 12(13-14):569-76. PubMed ID: 17631252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
    Moffatt DC; Bernstein CN
    Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.